Navigation Links
Kendle Announces First Quarter 2009 Results
Date:5/6/2009

57,977 59,170 Reimbursable out-of-pocket costs 36,958 44,689 Selling, general and administrative expenses 38,030 37,624 Depreciation and amortization 3,958 3,355 Total costs and expenses 136,923 144,838 Income from operations 8,138 13,975 Other income (expense): Interest expense (3,876) (4,437) Interest income 230 252 Other 3,163 (2,608) Total other (expense) (483) (6,793) Income before income taxes 7,655 7,182 Income taxes 6,769 3,078 Net income $886 $4,104 Income per share data: Basic: Net income per share $0.06 $0.28 Weighted average shares outstanding 14,842 14,690 Diluted: Net income per share $0.06 $0.27 Weighted average shares outstanding 14,975 14,975 Reconciliation of proforma net income: Net income $886 $4,104 Additional interest expense due to adoption of APB 14-1 1,672 1,520 Discrete tax item related to foreign currency hedge 4,441 - Proforma net income (2) $6,999 $5,624 Proforma net income per share (2) Basic $0.47 $0.38 Diluted $0.47 $0.38
'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
10. Kendle to Present at the Wachovia 2008 Healthcare Conference
11. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... CO (PRWEB) , ... June 30, 2015 , ... ... today announced that it has hired Gem Swartz to head up its account management ... senior account director. Both Gem and Amanda bring senior account management and delivery expertise ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company focused on the development ... participant in its Phase 1/2 clinical trial of ... unilateral Achilles tendinosis, has been enrolled and their ... ultrasound-guided injections. RCT-01 is comprised of non-bulbar dermal ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... launching SmartArch — a revolutionary new archwire that allows orthodontists to simultaneously apply ... evidence of the efficacy of SmartArch. “We’re thrilled about taking SmartArch one step ...
(Date:6/29/2015)... Pharnext SAS today announced that data related to its ... Type 1A (CMT1A), is being presented in four posters and ... Biennial Meeting at the Quebec Congress Center in ... 2015. At Poster Viewing Session 4, four posters ... EDT: Poster 23: "A Meta-Analysis Of Randomized ...
Breaking Biology Technology:Matrix Marketing Group Expands Client Services Team 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4New case studies for SmartArch orthodontic archwire paves way to product launch later this year 2Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2
... , , , , , , ... , AUDIO: A team ... Click here for more information. , ... , , , , ...
... , SEATTLE, Nov. 20 Dendreon Corporation ... and Drug Administration (FDA) provided written acknowledgement that the Company,s ... complete response. The FDA has assigned a Prescription Drug ... which time it will respond to Dendreon,s amended BLA. ...
... , SEATTLE, Nov. 20 Cell Therapeutics, Inc. (CTI) (Nasdaq ... Appeals reversed a U.S. District Court order and ruled that CTI ... Lash Group, sending the case back to the District Court for ... former third-party reimbursement consultant for CTI,s product TRISENOX, in 2007 seeking ...
Cached Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
(Date:6/30/2015)... Pa. , June 30, 2015 ... the company as CEO to help further develop Genisphere,s ... wealth of partnering experience, having spent much of the ... including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. ... focus on Technology and Biotech Corporate Finance. He graduated ...
(Date:6/29/2015)... , June 24, 2015 ... of the "Latin America Biomedical Sensors Market - ... offering. The Latin America Biomedical Sensors market ... CAGR of 2.04% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Latin America Biomedical Sensors Market Report 2015-2020 2
... announces the latest edition of an essential ... rapidly changing fields of clinical medicine. Covering novel viruses, ... informs scientists and health care professionals about all ... "Virology is currently one of the ...
... 2009The relationships between food, nutrition science, and health outcomes ... variation among individuals and populations is a new factor ... relationships. Hence, the rapidly emerging intersection of nutritional science ... a special issue of OMICS: A Journal of ...
... up a gas tank when the gasoline price hit close ... consumes fuel, which not only increases our vulnerability to foreign ... that will impact adverse change in climate and global warming. ... developing techniques that will lessen our monetary pain at the ...
Cached Biology News:New edition available for essential virology reference 2Nutrigenomics -- developing personalized diets for disease prevention -- part 2 just published in OMICS 2Engineer devises ways to improve gas mileage 2Engineer devises ways to improve gas mileage 3
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Human Rad1 MAb (Clone 33)...
Biology Products: